KRT17 and breast cancer: Analysis of TCGA data showed that KRT17 expression was lower in the luminal-A, luminal-B and HER2+ subtypes of BC than in normal tissues, but there was no significant difference in expression between the basal-like subtype (i.e., most TNBCs) and normal tissues.